Former Google CEO Eric Schmidt Headlines Inaugural NTI Innovation Forum
NTI Co-Chair and CEO Ernest J. Moniz hosted Eric Schmidt, former CEO and chairman of Google, for a conversation about how today’s emerging technologies will fundamentally alter global security—and society at large.
NTI Highlights Nuclear Effects Research at the Second Meeting of States Parties to the Treaty on the Prohibition of Nuclear Weapons
NTI Program Officer Patricia Jaworek joined a panel discussion on the devastating humanitarian effects of nuclear weapons and shared her research on the subject.
NTI | bio Convenes Workshop on Disincentivizing State Bioweapons Development and Use
NTI | bio convened a workshop on “Disincentivizing State Bioweapons Development and Use” a week ahead of the Biological Weapons Convention Working Group meetings in Geneva, Switzerland.
NTI | bio VP signs on to “Eight Commonsense Actions on Biosafety and Biosecurity”
NTI | bio Vice President Jaime Yassif is one of several dozen senior-level expert signatories on a recent Center for Strategic and International Studies (CSIS) report, “Eight Commonsense Actions for Biosafety and Biosecurity.”
New global Playbook for nuclear energy outlines pathways to scale up new projects
"This will help create a global nuclear ecosystem that can deliver historically large annual nuclear deployments for an extended period and meet strong nonproliferation and nuclear security standards,” said NTI Co-Chair and CEO Ernest J. Moniz
International Biosecurity and Biosafety Initiative for Science Accepted to Paris Peace Forum Scale Up Program
IBBIS was selected as one of 10 initiatives to receive support from the Paris Peace Forum community to accelerate its efforts to strengthen biosecurity norms and reduce risks associated with advances in technology.
NTI | bio Holds Congressional Event on Convergence of AI and the Life Sciences
NTI | bio hosted a lunchtime event on Capitol Hill to discuss how Congress and other decisionmakers can take action to mitigate emerging risks associated with AI-bio capabilities.